Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Praxis Precision Medicines, Inc.(PRAX) | 1,000,000 | 950,000 | -50,000 | $53.00M | $280.00M | 15.87% | +$227.00M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 17,878,594 | 17,878,594 | 0 | $207.03M | $223.84M | 12.69% | +$16.81M |
| ABIVAX Société AnonymeADS(ABVX) | 1,950,000 | 1,350,000 | -600,000 | $165.56M | $182.05M | 10.32% | +$16.50M |
| EyePoint, Inc.(EYPT) | 8,325,000 | 8,265,000 | -60,000 | $118.55M | $151.00M | 8.56% | +$32.45M |
| Rapport Therapeutics, Inc.(RAPP) | 3,192,521 | 3,027,521 | -165,000 | $94.82M | $91.85M | 5.21% | -$2.96M |
| BridgeBio Pharma, Inc.(BBIO) | 1,400,000 | 1,200,000 | -200,000 | $72.72M | $91.79M | 5.20% | +$19.07M |
| Bright Minds Biosciences Inc.(DRUG) | 1,059,331 | 1,059,331 | 0 | $64.26M | $82.67M | 4.69% | +$18.41M |
| Edgewise Therapeutics, Inc.(EWTX) | 4,010,000 | 3,285,000 | -725,000 | $65.04M | $81.52M | 4.62% | +$16.48M |
| Olema Pharmaceuticals, Inc.(OLMA) | 0 | 2,750,000 | +2,750,000 | $0 | $68.75M | 3.90% | +$68.75M |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 1,994,173 | 4,355,433 | +2,361,260 | $14.30M | $57.40M | 3.25% | +$43.11M |
| Insmed Incorporated(INSM) | 430,000 | 275,000 | -155,000 | $61.92M | $47.86M | 2.71% | -$14.06M |
| Engene Holdings Inc COM | 2,323,595 | 4,000,000 | +1,676,405 | $15.87M | $36.12M | 2.05% | +$20.25M |
| Alumis Inc | 2,147,396 | 3,635,596 | +1,488,200 | $8.57M | $35.48M | 2.01% | +$26.92M |
| MBX Biosciences, Inc.(MBX) | 1,225,000 | 1,120,000 | -105,000 | $21.44M | $35.32M | 2.00% | +$13.89M |
| Newamsterdam Pharma Company ORDINARY SHARES | 2,175,000 | 1,000,000 | -1,175,000 | $61.86M | $35.08M | 1.99% | -$26.78M |
| Centessa Pharmaceuticals PlcADS | 1,925,000 | 1,325,000 | -600,000 | $46.68M | $33.14M | 1.88% | -$13.54M |
| Pharvaris N V COM | 1,363,200 | 1,083,000 | -280,200 | $34.01M | $30.05M | 1.70% | -$3.96M |
| BioAge Labs, Inc.(BIOA) | 2,140,605 | 2,040,605 | -100,000 | $12.59M | $27.00M | 1.53% | +$14.41M |
| Ascendis Pharma A/SADR(ASND) | 0 | 100,000 | +100,000 | $0 | $21.32M | 1.21% | +$21.32M |
| Tarsus Pharmaceuticals, Inc.(TARS) | 300,000 | 250,000 | -50,000 | $17.83M | $20.47M | 1.16% | +$2.64M |
| Corbus Pharmaceuticals Holdings, Inc.(CRBP) | 2,375,000 | 2,344,971 | -30,029 | $30.04M | $19.09M | 1.08% | -$10.96M |
| GH Research PLC(GHRS) | 1,916,439 | 1,300,000 | -616,439 | $27.41M | $16.51M | 0.94% | -$10.90M |
| Oruka Therapeutics, Inc.(ORKA) | 533,340 | 533,340 | 0 | $10.26M | $16.17M | 0.92% | +$5.91M |
| Arcutis Biotherapeutics, Inc.(ARQT) | 775,000 | 500,000 | -275,000 | $14.61M | $14.52M | 0.82% | -$88.8K |
| Crinetics Pharmaceuticals In | 400,000 | 300,000 | -100,000 | $16.66M | $13.96M | 0.79% | -$2.69M |
| Axsome Therapeutics, Inc.(AXSM) | 100,000 | 75,000 | -25,000 | $12.14M | $13.70M | 0.78% | +$1.55M |
| Cabaletta Bio, Inc.(CABA) | 5,000,000 | 4,400,000 | -600,000 | $11.70M | $9.64M | 0.55% | -$2.06M |
| Janux Therapeutics, Inc.(JANX) | 850,000 | 650,000 | -200,000 | $20.77M | $8.97M | 0.51% | -$11.80M |
| Cogent Biosciences, Inc.(COGT) | 0 | 225,000 | +225,000 | $0 | $7.99M | 0.45% | +$7.99M |
| Vaxcyte, Inc.(PCVX) | 175,000 | 125,000 | -50,000 | $6.30M | $5.77M | 0.33% | -$536.0K |
| Amylyx Pharmaceuticals, Inc.(AMLX) | 500,000 | 400,000 | -100,000 | $6.79M | $4.83M | 0.27% | -$1.96M |
| Biohaven Ltd.(BHVN) | 10,000 | 10,000 | 0 | $150.1K | $112.9K | 0.01% | -$37.2K |
| Arcellx Inc COMMON STOCK | 775,000 | 0 | -775,000 | $63.63M | $0 | — | -$63.63M |
| Avidity Biosciences Inc | 300,000 | 0 | -300,000 | $13.07M | $0 | — | -$13.07M |
| Biomea Fusion, Inc.(BMEA) | 3,570,872 | 0 | -3,570,872 | $7.21M | $0 | — | -$7.21M |
| CG Oncology, Inc.(CGON) | 625,000 | 0 | -625,000 | $25.18M | $0 | — | -$25.18M |
| Enliven Therapeutics Inc | 200,000 | 0 | -200,000 | $4.09M | $0 | — | -$4.09M |
| Korro Bio, Inc.(KRRO) | 465,000 | 0 | -465,000 | $22.27M | $0 | — | -$22.27M |
| Metsera Inc | 400,000 | 0 | -400,000 | $20.93M | $0 | — | -$20.93M |